Epidemiological and molecular characterization of staphylococcus haemolyticus strains, from a hematology ward, with decreased susceptibility to glycopeptides

Canadian Journal of Microbiology

Volumn 57, Issue 6, 2011, Pages 476-484

  Ma, Xiao Xue ^a   Sun, Dan Dan ^a   Hu, Jian ^a   Wang, En Hua ^a   Luo, En Jie ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Glycopeptide resistance; Mec gene complex; MRSH clone; PFGE; Staphylococcus haemolyticus

Indexed keywords

GLYCOPEPTIDE RESISTANCE; MEC GENE COMPLEX; MRSH CLONE; PFGE; STAPHYLOCOCCUS HAEMOLYTICUS;

CLONING; ELECTROPHORESIS; GENES; HOSPITALS; TEACHING;

PEPTIDES;

TEICOPLANIN; VANCOMYCIN;

ANTIBIOTICS; BACTERIUM; CLONE; DISEASE CONTROL; DISEASE TRANSMISSION; ELECTROKINESIS; EPIDEMIOLOGY; HEMATOLOGY; INHIBITOR; MOLECULAR ANALYSIS;

ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CLONE; CONTROLLED STUDY; DRUG SENSITIVITY; EPIDEMIOLOGY; HEMATOLOGY; HUMAN; IN VIVO STUDY; INFECTION CONTROL; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR BIOLOGY; MONITORING; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS INFECTION; TEACHING HOSPITAL; WARD;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENES, BACTERIAL; HOSPITALS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; STAPHYLOCOCCUS HAEMOLYTICUS; TEICOPLANIN; VANCOMYCIN;

STAPHYLOCOCCUS HAEMOLYTICUS;

EID: 79958825202     PISSN: 00084166     EISSN: 14803275     Source Type: Journal    
DOI: 10.1139/w11-033     Document Type: Article

References (35)

1. Archer, G.L., Niemeyer, D.M., Thanassi, J.A., and Pucci, M.J. 1994. Dissemination among staphylococci of DNA sequences associated with methicillin resistance. Antimicrob. Agents Chemother. 38(3): 447-454. PMID:7911288.
2. Cercenado, E., Garcia-Leoni, M.E., Diaz, M.D., Sanchez-Carrillo, C., Catalan, P., De Quirós, J.C., and Bouza, E. 1996. Emergence of teicoplanin-resistant coagulase-negative staphylococci. J. Clin. Microbiol. 34(7): 1765-1768. PMID:8784585.
3. Clinical and Laboratory Standards Institute. 2009a. Performance standards for antimicrobial susceptibility testing. Nineteenth Informational Supplement, M100-S19. Clinical and Laboratory Standards Institute, Wayne, Penn., USA.
4. Clinical and Laboratory Standards Institute. 2009b. Method for dilution antimicrobial susceptibility tests for bacterial that grow aerobically; approved standard - eighth edition. M07-A8. Clinical and Laboratory Standards Institute, Wayne, Penn., USA.
5. Cremniter, J., Slassi, A., Quincampoix, J.C., Sivadon-Tardy, V., Bauer, T., Porcher, R., et al. 2010. Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative staphylococci isolated from orthopedic-device-associated infections. J. Clin. Microbiol. 48(4): 1428-1431. doi:10.1128/JCM.02098-09. PMID: 20164270.
6. Cui, L., Ma, X., Sato, K., Okuma, K., Tenover, K.C., Mamizuka, E. M., et al. 2003. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J. Clin. Microbiol. 41(1): 5-14. doi:10.1128/JCM.41.1.5-14.2003. PMID: 12517819.
7. de Allori, M.C., Jure, M.A., Romero, C., and de Castillo, M.E. 2006. Antimicrobial resistance and production of biofilms in clinical isolates of coagulase-negative Staphylococcus strains. Biol. Pharm. Bull. 29(8): 1592-1596. doi:10.1248/bpb.29.1592. PMID:16880610.
8. Deighton, M.A., Franklin, J.C., Sepicer, W.J., and Balkau, B. 1988. Species identification, antibiotic sensitivity and slime production of coagulase-negative staphylococci isolated from clinical specimens. Epidemiol. Infect. 101(1): 99-113. doi:10.1017/ S0950268800029265. PMID:3402550.
9. Del'Alamo, L., Cereda, R.F., Tosin, I., Miranda, E.A., and Sader, H.S. 1999. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides. Diagn. Microbiol. Infect. Dis. 34(3): 185-191. doi:10.1016/S0732-8893(99)00034-6. PMID:10403098.
10. Falcone, M., Micozzi, A., Pompeo, M.E., Baiocchi, P., Fabi, F., Penni, A., et al. 2004. Methicillin-resistant staphylococcal bacteremia in patients with hematologic malignancies: clinica and microbiological retrospective comparative analysis of S. haemolyticus, S. epidermidis and S. aureus. J. Chemother. 16(6): 540-548. PMID:15700845.
11. Froggatt, J.W., Johnston, J.L., Galetto, D.W., and Archer, G.L. 1989. Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus. Antimicrob. Agents Chemother. 33(4): 460-466. PMID:2729941.
12. Hiramatsu, K., Asada, K., Suzuki, E., Okonogi, K., and Yokota, T. 1992. Molecular cloning and nucleotide sequence determination of the regulator region of mecA gene in methicillin-resistant Staphylococcus aureus (MRSA). FEBS Lett. 298(2-3): 133-136. doi:10.1016/0014-5793(92)80039-J. PMID:1544435.
13. Isaac, D.W., Pearson, T.A., Hurwitz, C.A., and Patrick, C.C. 1993. Clinical and microbiologic aspects of Staphylococcus haemolyticus infections. Pediatr. Infect. Dis. J. 12(12): 1018-1021. PMID: 8108209.
14. Ito, T., Katayama, Y., Asada, K., Mori, N., Tsutsumimoto, K., Tiensasitorn, C., and Hiramatsu, K. 2001. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45(5): 1323-1336. doi:10.1128/AAC.45.5.1323-1336.2001. PMID:11302791.
15. Ito, T., Ma, X.X., Takeuchi, F., Okuma, K., Yuzawa, H., and Hiramatsu, K. 2004. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob. Agents Chemother. 48(7): 2637-2651. doi:10.1128/AAC.48.7.2637-2651.2004. PMID: 15215121.
16. Katayama, Y., Takeuchi, F., Ito, T., Ma, X.X., Ui-Mizutani, Y., Kobayashi, I., and Hiramatsu, K. 2003. Identification in methicillin-susceptible Staphylococcus hominis of an active primordial mobile genetic element for the staphylococcal cassette chromosome mec of methicillin-resistant Staphylococcus aureus. J. Bacteriol. 185(9): 2711-2722. doi:10.1128/JB.185.9.2711- 2722.2003. PMID:12700250.
17. Kleeman, K.T., Bannerman, T.L., and Kloos, W.E. 1993. Species distribution of coagulase-negative staphylococcal isolates at a community hospital and implications for selection of staphylococcal identification procedures. J. Clin. Microbiol. 31(5): 1318-1321. PMID:8501235.
18. Kloos, W.E., and Bannerman, T.L. 1994. Update on clinical significance of coagulase-negative staphylococci. Clin. Microbiol. Rev. 7(1): 117-140. PMID:8118787.
19. Ma, X.X., Ito, T., Tiensasitorn, C., Jamklang, M., Chongtrakool, P., Boyle-Vavra, S., et al. 2002. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillinresistant Staphylococcus aureus strains. Antimicrob. Agents Chemother. 46(4): 1147-1152. doi:10.1128/AAC.46.4.1147- 1152.2002. PMID:11897611.
20. Maniati, M., Petinaki, E., Kontos, A.N., Maniatis, I., Spiliopoulou, D., Petropoulou-Mylona, D., et al. 2005. Rapid increase in numbers of Staphylococcus epidermidis strains with reduced susceptibility to teicoplanin in Greece. Int. J. Antimicrob. Agents, 25(4): 346-348. doi:10.1016/j.ijantimicag.2005.01.015. PMID: 15849876.
21. Matsuhashi, M., Song, M.D., Ishino, F., Wachi, M., Doi, M., Inoue, M., et al. 1986. Molecular cloning of the gene of a penicillinbinding protein supposed to cause high resistance to b-lactam antibiotics in Staphylococcus aureus. J. Bacteriol. 167(3): 975- 980. PMID:3638304.
22. Okuma, K., Iwakawa, K., Turnidge, J.D., Grubb, W.B., Bell, J.M., O'Brien, F.G., et al. 2002. Dissemination of new methicillinresistant Staphylococcus aureus clones in the community. J. Clin. Microbiol. 40(11): 4289-4294. doi:10.1128/JCM.40.11.4289- 4294.2002. PMID:12409412.
23. Palazzo, I.C., Araujo, M.L., and Darini, A.L. 2005. First report of vancomycin-resistant staphylococci isolated from healthy carriers in Brazil. J. Clin. Microbiol. 43(1): 179-185. doi:10.1128/JCM. 43.1.179-185.2005. PMID:15634969.
24. Piette, A., and Verschraegen, G. 2009. Role of coagulase-negative staphylococci in human disease. Vet. Microbiol. 134(1-2): 45-54. doi:10.1016/j.vetmic.2008.09.009. PMID:18986783.
25. Schmidt, B.K., Kirpalani, H.M., Corey, M., Low, D.E., Philip, A.G., and Ford-Jones, E.L. 1987. Coagulase-negative staphylococci as true pathogens in newborn infants: a cohort study. Pediatr. Infect. Dis. J. 6(11): 1026-1031. PMID:2447554.
26. Sieradzki, K., Villari, P., and Tomasz, A. 1998. Decreased susceptibilities to teicoplanin and vancomycin among coagulasenegative methicillin-resistant clinical isolates of staphylococci. Antimicrob. Agents Chemother. 42(1): 100-107. PMID:9449268.
27. Song, M.D., Wachi, M., Doi, M., Ishino, F., and Matsuhashi, M. 1987. Evolution of an inducible penicillin-target protein in methicillin-resistant Staphylococcus aureus by gene fusion. FEBS Lett. 221(1): 167-171. doi:10.1016/0014-5793(87)80373-3. PMID:3305073.
28. Srinivasan, A., Dick, J.D., and Perl, T.M. 2002. Vancomycin resistance in staphylococci. Clin. Microbiol. Rev. 15(3): 430-438. doi:10.1128/CMR.15.3.430-438.2002. PMID:12097250.
29. Tabe, Y., Nakamura, A., and Igari, J. 2001. Glycopeptide susceptibility profiles of nosocomial multiresistant Staphylococcus haemolyticus isolates. J. Infect. Chemother. 7(3): 142-147. doi:10.1007/s101560100026. PMID:11810575.
30. Tacconelli, E., Tumbarello, M., Donati, K.G., Bettio, M., Spanu, T., Leone, E., et al. 2001. Glycopeptide resistance among coagulasenegative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study. Clin. Infect. Dis. 33(10): 1628-1635. doi:10.1086/323676. PMID:11595984.
31. Tenover, F.C., Arbeit, R.D., Goering, R.V., Mickelsen, P.A., Murray, B.E., Persing, D.H., and Swaminathan, B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33(9): 2233-2239. PMID:7494007.
32. Trueba, F., Garrabe, E., Hadef, R., Fabre, R., Cavallo, J.D., Tsvetkova, K., and Chesneau, O. 2006. High prevalence of teicoplanin resistance among Staphylococcus epidermidis strains in a 5-year retrospective study. J. Clin. Microbiol. 44(5): 1922-1923. doi:10.1128/JCM.44.5.1922-1923.2006. PMID:16672444.
33. Van Bambeke, F. 2006. Glycopeptides and glycodepsipeptides in clinical development: a comparative review of their antibacterial spectrum, pharmacokinetics and clinical efficacy. Curr. Opin. Investig. Drugs, 7(8): 740-749. PMID:16955686.
34. Wong, S.S., Ho, P.L., Woo, P.C., and Yuen, K.Y. 1999. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin. Infect. Dis. 29(4): 760-767. doi:10.1086/520429. PMID:10589883.
35. Yu, M.H., Chen, Y.G., Yu, Y.S., Chen, C.L., and Li, L.J. 2010. Antimicrobial resistance and molecular characterization of Staphylococcus haemolyticus in a Chinese hospital. Eur. J. Clin. Microbiol. Infect. Dis. 29(5): 613-616. doi:10.1007/s10096-010- 0893-3. PMID:20204444.